Skip to main content

Table 2 Clinicopathological differences between cases with cutaneous LMS and subcutaneous LMS

From: Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases

 

Cutaneous LMS (n = 42)

Subcutaneous LMS (n = 166)

p-value

Age

63 [31-89]

62 [1- 88]

0.976

Size (cm)

4.00 [0.50-12.40]

5.00 [0.50-50.00]

0.002

Definitive surgery

   

 Simple tumorectomy

32 (82.1%)

19 (11.9%)

<0.001

 With orchiectomy

7 (17.9%)

140 (88.1%)

 

Surgical margin

   

 Negative

20 (100.0%)

36 (81.8%)

0.049

 Positive

0 (0.0%)

8 (18.2%)

 

Tumor grade

   

 Grade 1

13 (41.9%)

40 (27.2%)

0.101

 Grade 2

11 (35.5%)

50 (34.0%)

 

 Grade 3

7 (22.6%)

57 (38.8%)

 

Adjuvant radiation therapy

   

 No

34 (89.5%)

121 (81.8%)

0.333

 Yes

4 (10.5%)

27 (18.2%)

 

Adjuvant chemotherapy

   

 No

36 (94.7%)

137 (92.6%)

1.000

 Yes

2 (5.3%)

11 (7.4%)

Â